Bevacizumab biosimilar (Qilu Pharma) |
QL-1101 |
Approved |
Qilu Pharmaceutical Co Ltd |
安可达 |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Qilu Pharmaceutical Co Ltd |
2019-12-06 |
Neoplasms; Colorectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Innovent Biologics) |
IBI-305; IBI305; IBI 305; CHS-305 |
Approved |
Innovent Biologics(Suzhou) Co Ltd |
达攸同, BYVASDA, Bevagen |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Innovent Biologics(Suzhou) Co Ltd |
2020-06-17 |
Ovarian Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Pfizer) |
PF-6439535; PF-06439535 |
Approved |
Pfizer Inc |
Zirabev |
EU |
Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Pfizer Europe Ma Eeig |
2019-02-14 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Elea) |
|
Approved |
Laboratorio Elea Phoenix Sa |
Lumiere |
Argentina |
Macular Degeneration |
Laboratorio Elea Phoenix Sa |
2018-04-26 |
Macular Degeneration |
Details
|
Bevacizumab biosimilar (Samsung Bioepis) |
SP-8; SB-8 |
Approved |
Samsung Bioepis Co Ltd |
Aybintio |
EU |
Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Uterine Cervical Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Peritoneal Neoplasms |
Samsung Bioepis Nl Bv |
2020-08-19 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Samsung Bioepis) |
AM002; SB-11; SB11 |
Approved |
Samsung Bioepis Co Ltd |
BYOOVIZ |
EU |
Macular Edema; Diabetic Retinopathy; Wet Macular Degeneration; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic macular oedema |
Samsung Bioepis Nl Bv |
2021-08-18 |
Macular Edema; Wet Macular Degeneration; Diabetic macular oedema; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion; Choroidal Neovascularization |
Details
|
Bevacizumab biosimilar (Intas Pharmaceuticals) |
INTP-24 |
Approved |
Intas Biopharmaceuticals |
Bevatas |
India |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Uterine Cervical Neoplasms; Glioblastoma; Carcinoma, Renal Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms |
Intas Biopharmaceuticals |
2017-10-04 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Formycon/Bioeq) |
CHS-201; FYB-201 |
Approved |
Formycon AG, Bioeq Gmbh |
CIMERLI, Ranivisio |
United States |
Macular Edema; Retinal Vein Occlusion; Choroidal Neovascularization; Macular Degeneration; Diabetic Retinopathy; Diabetic macular oedema; Wet Macular Degeneration |
Coherus Biosciences Inc |
2022-08-02 |
Macular Edema; Wet Macular Degeneration; Diabetic macular oedema; Diabetes Complications; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic Retinopathy; Macular Degeneration |
Details
|
Bevacizumab biosimilar (AryoGen Biopharma) |
BE1040V |
Approved |
Aryogen Biopharma |
Stivant |
Iran |
Uterine Cervical Neoplasms; Metastatic breast cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Glioblastoma |
Aryogen Biopharma |
2019-06-01 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Shanghai Institute Of Biological Products) |
SIBP-04 |
Approved |
Shanghai Institute Of Biological Products Co Ltd |
生唯宁 |
Mainland China |
Colorectal Neoplasms; Glioblastoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Ovarian Neoplasms |
Shanghai Institute Of Biological Products Co Ltd |
2025-01-08 |
Ovarian Neoplasms; Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (Zydus Cadila) |
|
Approved |
Zydus Cadila |
Bryxta |
India |
Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Glioblastoma; Metastatic breast cancer; Carcinoma, Renal Cell |
Zydus Cadila |
2017-01-01 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (TOT Biopharm) |
TAB-008; TOT-102; TAB008; TOT102 |
Approved |
Tot Biopharm Co Ltd |
朴欣汀, Pusintin |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Tot Biopharm Co Ltd |
2021-12-01 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab |
G180CU; RO-4876646; RG-435; NSC-704865; G180CL; R-435; G180DL |
Approved |
Genentech Inc |
安维汀, Avastin |
United States |
Colorectal Neoplasms |
Genentech Inc |
2004-02-26 |
Liver Neoplasms; Infections; Respiratory Tract Infections; Pterygium; Ovarian Neoplasms; Solid tumours; Arteriovenous Malformations; Kidney Neoplasms; Head and Neck Neoplasms; Fibrosarcoma; Leiomyosarcoma; Epistaxis; Telangiectasia, Hereditary Hemorrhagic; Leukemia; HIV Infections; Leukemia, Myelogenous, Chronic; Ependymoma; Skin Melanoma; Meningeal Carcinomatosis; Telangiectasis; Diabetes Mellitus, Type 2; Macular Edema; Carcinoma, Renal Cell; Carcinoma, Basal Cell; Esthesioneuroblastoma, Olfactory; Carcinoid Tumor; Rectal Neoplasms; Carcinoma; Hemangioblastoma; Granuloma, Lethal Midline; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Vaginal Neoplasms; Esophageal Neoplasms; Neoplasms, Glandular and Epithelial; Virus Diseases; Papillomavirus Infections; Neoplasms, Squamous Cell; Respiratory Tract Diseases; Glioblastoma; Carcinoma, Ovarian Epithelial; Neoplasms; Pancreatic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Verrucous; Salivary Gland Neoplasms; Nose Neoplasms; Colonic Neopla |
Details
|
Bevacizumab biosimilar(Dr. Reddy's Laboratories) |
DRL-BZ |
Approved |
Dr.Reddy's Laboratories Ltd |
Versavo, Persivia |
India |
Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Glioblastoma; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell |
Dr.Reddy's Laboratories Ltd |
2019-08-19 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Celltrion) |
CTP-16; CT-16; CT-P16 |
Approved |
Celltrion Inc |
Vegzelma |
EU |
Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Carcinoma, Renal Cell |
Celltrion Healthcare Hungary Kft |
2022-08-17 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Aflibercept biosimilar (Momenta/Mylan) |
M-710; MYL-1701P |
Approved |
Momenta, Mylan Nv |
YESAFILI |
EU |
Myopia, Degenerative; Diabetic Retinopathy; Retinal Vein Occlusion; Diabetes Complications; Macular Edema |
Viatris Ltd |
2023-09-15 |
Macular Edema; Myopia, Degenerative; Diabetic macular oedema; Wet Macular Degeneration; Diabetes Complications; Diabetic Retinopathy; Retinal Vein Occlusion |
Details
|
Ranibizumab biosimilar (Intas Biopharmaceuticals) |
|
Approved |
Intas Biopharmaceuticals |
Razumab |
India |
Macular Degeneration |
Intas Biopharmaceuticals |
2015-01-01 |
Macular Degeneration |
Details
|
Bevacizumab biosimilar (Outlook) |
ONS-5010; ONS-1045 |
Approved |
Outlook Therapeutics Inc |
Lytenava |
EU |
Wet Macular Degeneration |
Outlook Therapeutics Ltd, null |
2024-05-27 |
Wet Macular Degeneration; Diabetic macular oedema; Macular Degeneration; Retinal Vein Occlusion |
Details
|
Ranibizumab biosimilar (Xbrane) |
|
Approved |
Xbrane Biopharma Ab |
Ximluci |
EU |
Macular Edema; Wet Macular Degeneration; Diabetes Complications; Diabetic Retinopathy |
Stada Arzneimittel Ag |
2022-11-09 |
Macular Edema; Wet Macular Degeneration; Diabetes Complications; Macular Degeneration; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (Boan Biopharma) |
LY-01008; BA-1101 |
Approved |
Shandong Boan Biotechnology Co Ltd |
博优诺, Boyounuo |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Shandong Boan Biotechnology Co Ltd |
2021-05-07 |
Glioblastoma; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Shanghai Henlius Biotech) |
HLX-04; HLX04-O |
Approved |
Shanghai Henlius Biotech Inc |
汉贝泰 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Shanghai Henlius Biopharmaceuticals Co Ltd |
2021-11-30 |
Solid tumours; Carcinoma; Rectal Neoplasms; Carcinoma, Ovarian Epithelial; Glioblastoma; Wet Macular Degeneration; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Hepatocellular; Macular Degeneration; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Biocad) |
BCD-021 |
Approved |
BIOCAD JSC |
Avegra |
Russian Federation |
Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms; Glioblastoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial |
BIOCAD JSC |
2015-11-25 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Wet Macular Degeneration; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Macular Degeneration |
Details
|
Bevacizumab biosimilar (Sinocelltech) |
SCT-510; SCT510A; SCT-510A |
Approved |
SinoCelltech Ltd |
安贝珠 |
Mainland China |
Glioblastoma; Peritoneal Neoplasms; Uterine Cervical Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Colorectal Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
SinoCelltech Ltd |
2023-06-27 |
Ovarian Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Wet Macular Degeneration; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Macular Degeneration |
Details
|
Ranibizumab biosimilar (Qilu Pharmaceutical) |
BCD-300; QL-1205 |
Approved |
Biocnd, Qilu Pharmaceutical Co Ltd |
Rimmyrah |
EU |
Myopia, Degenerative; Macular Edema; Wet Macular Degeneration; Choroidal Neovascularization; Diabetes Complications |
Qilu Pharma Spain Sa |
2024-01-05 |
Macular Edema; Myopia, Degenerative; Wet Macular Degeneration; Diabetic macular oedema; Diabetes Complications; Macular Degeneration; Myopia; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (Allergan/Amgen) |
ABP-215 |
Approved |
Amgen Inc |
Mvasi |
United States |
Uterine Cervical Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma |
Amgen Inc |
2017-09-14 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Aflibercept biosimilar (Qilu Pharmaceutical) |
QL-1207 |
Approved |
Qilu Pharmaceutical Co Ltd |
|
Mainland China |
Macular Degeneration; Diabetic macular oedema |
Qilu Pharmaceutical Co Ltd |
2023-12-13 |
Wet Macular Degeneration; Diabetic macular oedema; Macular Degeneration |
Details
|
Ranibizumab biosimilar (Senju) |
GBS-007; OT-701; SJP-0133 |
Approved |
Senju Pharmaceutical Co Ltd |
|
Japan |
Macular Degeneration |
Senju Pharmaceutical Co Ltd |
2021-09-27 |
Wet Macular Degeneration; Macular Degeneration |
Details
|
Aflibercept biosimilar (Amgen) |
ABP-938 |
Approved |
Amgen Inc |
PAVBLU |
United States |
Diabetic Retinopathy; Macular Edema; Wet Macular Degeneration; Diabetic macular oedema |
Amgen Inc |
2024-08-23 |
Macular Edema; Wet Macular Degeneration; Vascular Diseases; Diabetic macular oedema; Macular Degeneration; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (mAbixience) |
MB02; BEVZ-92; BEVZ92-MB02; AP-01 |
Approved |
Mabxience Sa |
Alymsys |
Argentina |
Colorectal Neoplasms; Carcinoma, Renal Cell; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Stada Arzneimittel Ag |
2013-10-25 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Neovasculgen |
PI-VEGF165 |
Approved |
Human Stem Cells Institute |
Neovasculgen |
Russian Federation |
Peripheral Arterial Disease |
Human Stem Cells Institute |
2011-12-07 |
Peripheral Arterial Disease; Peripheral Nerve Injuries |
Details
|
Nivolumab/Hyaluronidase |
ONO-4538HSC |
Approved |
Bristol-Myers Squibb Company, Ono Pharmaceutical Co Ltd |
OPDIVO QVANTIG, Opdivo Qvantig |
United States |
Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Esophageal Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Hepatocellular |
Bristol-Myers Squibb Company |
2024-12-27 |
Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (CTTQ Pharma) |
TQ-B2302 |
Approved |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
安倍斯 |
Mainland China |
Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group |
2023-02-28 |
Ovarian Neoplasms; Rectal Neoplasms; Glioblastoma; Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Biocon/Mylan) |
MYL-1402O |
Approved |
Biocon Ltd |
Lextemy, KRABEVA, Abevmy |
India |
Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Ovarian Neoplasms; Brain Neoplasms |
Mylan Pharmaceuticals Private Ltd |
2017-11-27 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Brain Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Conbercept |
FP-3; KH-902 |
Approved |
Chengdu Kanghong Biotechnologies Co Ltd |
朗沐, Langmu |
Mainland China |
Macular Degeneration |
Chengdu Kanghong Biotechnologies Co Ltd |
2013-11-27 |
Vision Disorders; Macular Edema; Diabetic macular oedema; Wet Macular Degeneration; Hemangioma; Retinoblastoma; Uveitis; Macular Degeneration; Diabetes Mellitus; Corneal Neovascularization; Retinal Vein Occlusion; Choroidal Neovascularization |
Details
|
Bevacizumab biosimilar(Apotex ) |
|
Approved |
Apotex Inc |
BAMBEVI |
Canada |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Glioblastoma |
Apotex Inc |
2021-09-23 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Colorectal Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Aflibercept |
BAY-865321; BAT-86-5321 |
Approved |
Regeneron Pharmaceuticals Inc, Bayer AG |
Eylea, 艾力雅 |
United States |
Macular Degeneration; Macular Edema |
Regeneron Pharmaceuticals Inc |
2011-11-18 |
Wet Macular Degeneration; Corneal Neovascularization; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Retinopathy of Prematurity; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic Retinopathy; Macular Degeneration; Lymphoma, Non-Hodgkin; Retinal Degeneration; Eye Diseases; Vitreous Hemorrhage; Diabetes Complications; Colorectal Neoplasms; Prostatic Neoplasms; Drug-Related Side Effects and Adverse Reactions; Diabetic macular oedema; Retinitis Pigmentosa; Multiple Myeloma; Myopia, Degenerative; Retinal Diseases; Central Serous Chorioretinopathy; Colonic Neoplasms; Neoplasms; Choroid Diseases; Rectal Neoplasms; Diabetes Mellitus, Type 2; Glaucoma, Neovascular; Macular Edema; Cataract; Diabetes Mellitus, Type 1 |
Details
|
Bevacizumab biosimilar (Jiangsu Hengrui Medicine) |
BP-102 |
Approved |
Jiangsu Hengrui Medicine Co Ltd |
艾瑞妥 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Suzhou Suncadia Biopharmaceuticals Co Ltd |
2021-06-22 |
Solid tumours; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Aflibercept biosimilar (HEXAL/Sandoz) |
SOK-583A1; SOK583A1; SOK-583 |
Approved |
Sandoz, Hexal |
ENZEEVU, Afqlir |
United States |
Wet Macular Degeneration |
Sandoz Inc |
2024-08-09 |
Retinal Diseases; Wet Macular Degeneration; Macular Degeneration |
Details
|
Aflibercept biosimilar (Celltrion) |
CT-P42 |
Approved |
Celltrion Inc |
Eydenzelt |
South Korea |
Wet Macular Degeneration; Diabetic macular oedema |
Celltrion Inc |
2024-05-30 |
Wet Macular Degeneration; Diabetic macular oedema |
Details
|
Ziv-aflibercept |
BAY-865321; AVE-0005 |
Approved |
Regeneron Pharmaceuticals Inc, Sanofi |
Zaltrap |
United States |
Colorectal Neoplasms |
Sanofi-Aventis U.S. Llc |
2012-08-03 |
Endometrial Neoplasms; Urethral Neoplasms; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Ureteral Neoplasms; Genital Neoplasms, Female; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Astrocytoma; Gliosarcoma; Lung Neoplasms; Lymphoma; Metastatic breast cancer; Prostatic Neoplasms; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Thyroid Neoplasms; Glioma; Carcinoma, Neuroendocrine; Uterine Neoplasms; Fallopian Tube Neoplasms; Retinal Vein Occlusion; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma; Small Cell Lung Carcinoma; Skin Melanoma; Leukemia; Solid tumours; Multiple Endocrine Neoplasia Type 1; Leiomyosarcoma; Rectal Neoplasms; Carcinoma; Carcinoma, Renal Cell; Carcinoid Tumor; Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Carcinoma, Papillary; Ovarian Neoplasms; Myelodysplastic Syndromes; Carcinoma, Transitional Cell; Leukemia, Myelomonocytic, Chronic; Glioblastoma; Carcinoma, Ovarian Epithelial; L |
Details
|
Ranibizumab |
RG-3645; rhu-Fab-VEG; AMD-rhuFab-V2; AMD-Fab; rhuFab-V2; Y-0317; RFB-002; RG-6321 |
Approved |
Novartis Pharma Ag, Genentech Inc |
Lucentis, 诺适得, Susvimo |
United States |
Macular Degeneration |
Genentech Inc |
2006-06-30 |
Retinal Degeneration; Hemangioma; Retinoblastoma; Vascular Diseases; Retinal Detachment; Pseudoxanthoma Elasticum; Retinal Neovascularization; Cardiovascular Diseases; Diabetes Complications; Macular telangiectasia; Ischemia; Uveitis; Vitreous Hemorrhage; Eye Diseases; Glaucoma; Choroidal Neovascularization; Retinal Vein Occlusion; Diabetes Mellitus; Macular Degeneration; Diabetic Retinopathy; Myopia; Corneal Neovascularization; von Hippel-Lindau Disease; Conjunctival Neoplasms; Retinopathy of Prematurity; Port-Wine Stain; Melanoma; Macular telangiectasia 2; Strongyloidiasis; Optic Neuropathy, Ischemic; Polypoidal choroidal vasculopathy; Pterygium; Epistaxis; Telangiectasia, Hereditary Hemorrhagic; Retinal Telangiectasis; Cataract; Diabetic Angiopathies; Iris Diseases; Macular Edema; Depression; Telangiectasis; Vision Disorders; Vitreous Detachment; Glaucoma, Neovascular; Neovascularization, Pathologic; Central Serous Chorioretinopathy; Histoplasmosis; Myopia, Degenerative; Pathologic Processes; Retinal Disea |
Details
|
Aflibercept biosimilar (Bioeq) |
FYB-203 |
Approved |
Formycon AG |
AHZANTIVE, Baiama |
United States |
Diabetic Retinopathy; Macular Edema; Wet Macular Degeneration; Diabetic macular oedema; Retinal Vein Occlusion; Macular Degeneration |
Formycon AG |
2024-06-28 |
Macular Edema; Wet Macular Degeneration; Diabetic macular oedema; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion |
Details
|
Aflibercept biosimilar (Samsung Bioepis) |
SB-15; AM003; SB15 |
Approved |
Samsung Bioepis Co Ltd |
OPUVIZ, Opuviz, AFILIVU |
United States |
Diabetic macular oedema; Macular Edema; Wet Macular Degeneration; Diabetic Retinopathy |
Samsung Bioepis Co Ltd |
2024-05-20 |
Macular Edema; Diabetic macular oedema; Wet Macular Degeneration; Macular Degeneration; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (Reliance Life Sciences) |
R-TPR-023 |
Approved |
Reliance Life Sciences |
BevaciRel |
India |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Carcinoma, Renal Cell; Uterine Cervical Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms |
Reliance Life Sciences |
2016-06-13 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Hualan Biological Engineering) |
WBP-264 |
Approved |
Hualan Genetic Engineering Co Ltd |
|
Mainland China |
Peritoneal Neoplasms; Uterine Cervical Neoplasms; Colorectal Neoplasms; Glioblastoma; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung |
Hualan Genetic Engineering Co Ltd |
2024-11-15 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms |
Details
|
Faricimab |
RO-6867461; RG-7716 |
Approved |
F. Hoffmann-La Roche Ltd, Genentech Inc |
Vabysmo, 罗视佳 |
United States |
Wet Macular Degeneration; Diabetic macular oedema |
Genentech Inc |
2022-01-28 |
Polypoidal choroidal vasculopathy; Choroid Diseases; Macular Edema; Vision Disorders; Retinal Diseases; Wet Macular Degeneration; Diabetic macular oedema; Diabetes Complications; Choroidal Neovascularization; Myopia; Retinal Vein Occlusion; Macular Degeneration; Diabetes Mellitus; Diabetic Retinopathy |
Details
|
Ivonescimab |
SMT-112; AK-112 |
Approved |
Zhongshan Akeso Biopharma Co Ltd |
依达方 |
Mainland China |
Carcinoma, Non-Small-Cell Lung |
Akeso-Sino Pharma Co Ltd |
2024-05-24 |
Carcinoma, Neuroendocrine; Paget Disease, Extramammary; Sarcoma; Breast Neoplasms; Prostatic Neoplasms; Bile Duct Neoplasms; Genital Neoplasms, Female; Colorectal Neoplasms; Carcinoma, Squamous Cell; Endometrial Neoplasms; Carcinoma, Adenoid Cystic; Brain metastases; Penile Neoplasms; Angiomyolipoma; Paraganglioma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Neoplasm Metastasis; Esophageal Neoplasms; Rhabdomyosarcoma; Solid tumours; Kidney Neoplasms; Pheochromocytoma; Carcinoma; Carcinoma, Renal Cell; Carcinoma, Basal Cell; Urachal Cyst; Stomach Neoplasms; Ovarian Neoplasms; Neoplasms; Perivascular Epithelioid Cell Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Salivary Gland Neoplasms; Glioblastoma |
Details
|
Bevacizumab biosimilar (Hetero Drugs) |
|
Approved |
Hetero Drugs Ltd |
Cizumab |
India |
Colorectal Neoplasms |
Hetero Drugs Ltd |
2016-06-27 |
Colorectal Neoplasms |
Details
|
Bevacizumab biosimilar (Bio-Thera Solutions) |
BAT-1706; GP-2019 |
Approved |
Bio-Thera Solutions Ltd |
普贝希, AVZIVI |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Bio-Thera Solutions Ltd, BeOne Medicines Ltd |
2021-11-17 |
Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Betta/Mabworks) |
MIL-60 |
Approved |
Institute Of Basic Medicine, Chinese Academy Of Medical Sciences, Beijing Mabworks Biotech Co Ltd |
贝安汀 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Betta Pharmaceuticals Co Ltd |
2021-11-24 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|